Estrogen, bone, growth and sex: A sea change in conventional wisdom

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue SUPPL. 6, 2000, Pages 1439-1455

  Grumbach, M M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; Children; Estradiol; Estrogen action; Estrogen synthesis; Human growth; Mutations; Puberty; Sex differences; Skeletal maturation

Indexed keywords

ANDROGEN; AROMATASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA;

BIOSYNTHESIS; BONE MASS; BONE MATURATION; CONFERENCE PAPER; GROWTH; GROWTH ACCELERATION; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; NONHUMAN; SEX DIFFERENCE;

EID: 0034504525     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2000-s619     Document Type: Conference Paper

References (121)

1. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
2. Estrogen: Consequences and implications of human mutations in synthesis and action
3. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries
4. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)
5. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
6. Effect of testosterone and estradiol in a man with aromatase deficiency
7. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood
8. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency
9. Aromatase deficiency caused by a novel P450arom gene mutation: Impact of absent estrogen production on serum gonadotropin concentration in a boy
10. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
11. Expression of the CYP19 (aromatase) gene: An unusual case of alternative promoter usage
12. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes
13. Estrogen receptor null mice: What have we learned and where will they lead us?
14. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene
15. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
16. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern
17. The novel estrogen receptor β subtype: Potential role in the cell, promoter specific actions of estrogens, antiestrogens
18. Generation and reproductive phenotypes of mice lacking estrogen receptor β
19. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice
20. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
21. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
22. The role of insulin-like growth factors and binding proteins in bone cell biology
23. Puberty: Ontogeny, neuroendocrinology, physiology, and disorders
24. Growth hormones and sex steroid interactions at puberty
25. Role of extraglandular estrogen in human endocrinology
26. Aromatase in human bone tissue
27. Oestrogen formation from androstenedione in human bone
28. Steroid formation in osteoblast-like cells
29. Androstenedione metabolism in cultured human osteoblast-like cells
30. Local estradiol metabolism in osteoblast- and osteoclast-like cells
31. Aromatase in bone cell: Association with osteoporosis in postmenopausal women
32. Estradiol formation by human osteoblasts via multiple pathways: Relation with osteoblast function
33. Androgens regulate bone resorption activity of isolated osteoclasts in vitro
34. Steroid hormone receptor expression and action in bone
35. Localization of estrogen receptor-α in human and rabbit skeletal tissues
36. ERβ a novel estrogen receptor offers the potential for new drug development
37. Expression of estrogen receptor β in rat bone
38. Active role of chondrocyte apoptosis in endochondral ossification
39. Regulating the regulators of chondrocyte hypertrophy
40. Cell cycle genes in chondrocyte proliferation and differentiation
41. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation
42. Chondrocyte death is linked to development of a mitochondrial membrane permeability transition in the growth plate
43. Expression of the components of the insulin-like growth factor axis across the growth-plate
44. Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy
45. Cellular patterns of insulin-like growth factor system gene expression in murine chondrogenesis and osteogenesis
46. Insulin-like growth factors and skeletal growth: Possibilities for therapeutic interventions
47. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
48. Growth hormone and bone
49. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency
50. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation
51. Estrogen regulation of the insulin-like growth factor-I gene transcription involves an AP-1 enhancer
52. Hormonal changes in puberty: IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor
53. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay
54. Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: A semilongitudinal study throughout puberty in healthy boys
55. Diurnal rhythm of 17β-estradiol secretion throughout pubertal development in healthy girls: Evaluation by a sensitive radioimmunoassay
56. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay
57. Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement
58. Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogen in pubertal growth of girls
59. The contribution of testosterone to skeletal development and maintenance: Lessons from the androgen insensitivity syndrome
60. Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome
61. Origin of estrogen in normal men and in women with testicular feminization
62. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription
63. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads
64. Short term, low dose estradiol accelerates ulnar growth in boys
65. Treatment of familial male precocious puberty with spironolactone and deslorelin
66. The genetic transformation of bone biology
67. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfal
68. Hormone regulation of chondrocyte differentiation and endochondral bone formation
69. Chondrocytes in the endochondral growth cartilage are not hypoxic
70. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
71. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1
72. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
73. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
74. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation
75. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells
76. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland
77. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
78. Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors "α" and "β"
79. An address system in the vasculature of normal tissues and tumors
80. Estrogen replacement therapy in a man with congenital aromatase deficiency: Effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters
81. The differing tempo of growth in bone size, mass, and density in girls is region-specific
82. Bone growth from 11 to 17 years: Relationship to growth, gender and changes with pubertal status including timing of menarche
83. Bone mineral acquisition in adolescence
84. Bone mineral acquisition during adolescence
85. Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: A longitudinal study
86. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
87. Volumetric bone mineral density in normal subjects, aged 5-27 years
88. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis
89. Cellular and molecular regulation of bone turnover
90. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts
91. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer
92. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens
93. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
94. Action of androgens versus estrogens in male skeletal homeostasis
95. Androgens and bone metabolism
96. Identification of androgen receptors in normal human osteoblast-like cells
97. Androgen receptors in bone-forming tissue
98. The localization of androgen receptors in human bone
99. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor
100. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells
101. Androgen effects on bone metabolism: Recent progress and controversies
102. Androgens as anabolic agents for bone
103. Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations
104. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro
105. Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness
106. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat
107. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats
108. Ovarian androgens reduce bone loss, to a minor but significant degree, in rats treated with the anti-oestrogen ICI 182, 780
109. Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle - A model of endochondral ossification
110. An aged rat model of partial androgen deficiency: Prevention of both loss of bone and lean body mass by low-dose androgen replacement
111. Osteoblast gene expression in rat long bones: Effects of ovariectomy and dihydrotestosterone on mRNA levels
112. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice
113. Bone has a sexually dimorphic response to aromatase deficiency
114. Bone mineral density and body composition in young adult aromatase deficient mice
115. Immunofluorescent localization of estrogen receptor-α in growth plates of rabbits, but not in rats, at sexual maturity
116. Determinants of ligand specificity of estrogen receptorα: Estrogen versus androgen discrimination
117. Androgen-uterine interactions: An assessment of androgen interaction with the testosterone- and estrogen receptor systems and stimulation of uterine growth and progesterone-receptor synthesis
118. Estrogen regulation of the birth and death of bone cells
119. SXR, a novel steroid and xenobiotic-sensing nuclear receptor
120. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways
121. Nuclear receptor coregulators: Cellular and molecular biology